Compounding pharmacies will now be able to sell 6 popular peptides, despite the fact they have not been proved safe and effective.
GoodRx reports on 10 common issues that can delay prescription refills and offers solutions, emphasizing the importance of communication with pharmacists and prescribers.
GoodRx reports that FDA-approved peptides have undergone safety and effectiveness testing, while unapproved wellness peptides lack such evidence, posing risks.
The growing availability of these substances is worsening the already bad problem of sexual assault on campus.
Sexual enhancement supplements often contain unlisted prescription drugs that pose serious health risks.
Honeydew reports a new topical formulation of Accutane, promising fewer side effects for mild-to-moderate acne, but oral isotretinoin remains the cure for persistent cases.
GoodRx reports nine reasons a pharmacist may not fill a prescription, including missing information, drug shortages, and insurance issues, along with solutions to prevent delays.
On top of the risks of injecting untested and potentially contaminated products, user error may make this runaway wellness fad even more dangerous.
New weight-loss drugs have grown in popularity in recent years due to increased availability and the introduction of tablets.
Understood reports that the FDA has approved Simtriyo, a new ADHD medication targeting dopamine, norepinephrine, and serotonin, promising fewer side effects.